EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial use and stewardship opportunities in Burkina Faso: findings from the first Global Point Prevalence Survey in eight hospitals

André Yi Yè Aburi Nagalo iD, Ann Versporten iD, Odilon D Kaboré iD, Orokia S Momo, Noutin F Michodigni iD, Bintou Sanogo iD, Jacques Zoungrana iD, Ines Pauwels iD, Ibrahim Traoré iD, Armel Poda iD, Mahamoudou Sanou, Herman Goossens und 1 weitere

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)

DOI: 10.1017/ash.2026.10294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 05.02.2026. Verfasst von André Yi Yè Aburi Nagalo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire National de Référence des résistances aux antimicrobiens, Bobo-Dioulasso, Burkina Faso. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe the prevalence, patterns, and quality indicators of antimicrobial use (AMU) in Burkinabe hospitals and identify priorities for stewardship.

Design

Multicentre, cross-sectional point prevalence survey (PPS) following the Global Point Prevalence Survey protocol.

Setting

Eight public hospitals across six cities in Burkina Faso (3 primary, 3 secondary, and 2 tertiary), February–June 2019.

Participants

All inpatients present on the survey day at 8:00. Medical records were reviewed for those receiving systemic antimicrobial agents.

Methods

Standardized ward- and patient-level data were collected on indications, agents, routes, and WHO AWaRe categories, alongside quality indicators (documented indication, stop/review date, guideline compliance, and targeted vs empirical therapy). Descriptive analyses compared hospital tiers.

Results

Of 994 inpatients, 729 (73.3%) received ≥1 antimicrobial (range by tier: tertiary 69.7%, secondary 79.2%, primary 79.2%). Community-acquired infections accounted for 96.0% of therapeutic indications. Leading reasons were skin/soft tissue infections (12.2%), gastrointestinal infections (10.7%), and pneumonia (10.4%). Parenteral administration predominated. The most used agents were ceftriaxone (27.8%), metronidazole (15.7%), and gentamicin (9.4%). By AWaRe, Access agents comprised ∼ 50%, Watch agents ∼ 50% overall, with higher Watch use in tertiary hospitals; no Reserve antibiotics were recorded. Quality indicators were suboptimal: the indication was documented in 15.6%, the stop/review date was absent in 93.0%, and 41.1% of prescriptions were guideline-compliant. Therapy was largely empirical (98.5%). Prolonged surgical prophylaxis (>1 day) represented 86.8% of prophylaxis courses.

Conclusions

Antimicrobial use (AMU) prevalence in Burkinabe hospitals is high, dominated by empirical therapy and Watch-class ceftriaxone. Deficits in prescribing quality and limited diagnostic use highlight urgent needs for context-adapted antimicrobial stewardship: enforce guideline-concordant care, curb prolonged prophylaxis and unnecessary Watch-class use, and expand affordable microbiology capacity to enable targeted therapy.

Autor:innen und Institutionen

  • Laboratoire National de Référence des résistances aux antimicrobiens, Bobo-Dioulasso, Burkina Faso.
  • Laboratoire d'analyses biomédicales, Centre Hospitalier Universitaire Régional de Ouahigouya, Ouahigouya, Burkina Faso.
  • Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium.
  • Instituts des sciences de la santé, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso.
  • Unité de bactériologie-virologie, Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouagadougou, Burkina Faso.
  • Unité de Formation et de recherche en Sciences de la Santé, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

ORCID-Profile: André Yi Yè Aburi Nagalo, Ann Versporten, Odilon D Kaboré, Noutin F Michodigni, Bintou Sanogo, Jacques Zoungrana, Ines Pauwels, Ibrahim Traoré, Armel Poda, Abdoul-Salam Ouedraogo

Zitieren

APA

Nagalo, A. Y. Y. A., Versporten, A., Kaboré, O. D., Momo, O. S., Michodigni, N. F., Sanogo, B., Zoungrana, J., Pauwels, I., Traoré, I., Poda, A., Sanou, M., Goossens, H., & Ouedraogo, A. S. (2026). Antimicrobial use and stewardship opportunities in Burkina Faso: findings from the first Global Point Prevalence Survey in eight hospitals. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10294

Vancouver

Nagalo AYYA, Versporten A, Kaboré OD, Momo OS, Michodigni NF, Sanogo B, et al. Antimicrobial use and stewardship opportunities in Burkina Faso: findings from the first Global Point Prevalence Survey in eight hospitals. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10294

BibTeX
@article{Nagalo2026,
  author = {Nagalo, André Yi Yè Aburi and Versporten, Ann and Kaboré, Odilon D and Momo, Orokia S and Michodigni, Noutin F and Sanogo, Bintou and Zoungrana, Jacques and Pauwels, Ines and Traoré, Ibrahim and Poda, Armel and Sanou, Mahamoudou and Goossens, Herman and Ouedraogo, Abdoul-Salam},
  title = {Antimicrobial use and stewardship opportunities in Burkina Faso: findings from the first Global Point Prevalence Survey in eight hospitals},
  journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1017/ash.2026.10294}
}
Kostenlos starten →